Novo Nordisk A/S ADR (NVO) Social Stream



Novo Nordisk A/S ADR (NVO): $124.51

0.89 (-0.71%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

NOVO NORDISK A S (NVO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NOVO NORDISK A S.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $118.8 $115 $116.9 $106.69 9.57%
2022-02-09 4 $118.8 $115 $116.9 $106.69 9.57%
2022-04-19 4 $132.6 $115 $123.8 $106.69 16.04%
2022-04-25 4 $130 $118.8 $124.4 $106.69 16.6%
2022-05-12 5 $134.6 $130 $132.3 $106.69 24%
2022-06-16 5 $134.6 $130 $132.3 $106.69 24%
2022-08-05 7 $134.6 $130 $132.3 $106.69 24%
2022-12-03 8 $134.6 $130 $132.3 $106.69 24%
2022-12-13 8 $147 $130 $138.5 $106.69 29.82%
2023-02-01 8 $147 $145 $146 $106.69 36.85%
2023-02-28 8 $155 $147 $151 $106.69 41.53%
2023-03-01 8 $174 $155 $164.5 $106.69 54.19%
2023-04-13 10 $174 $155 $164.5 $106.69 54.19%
2023-05-10 9 $195 $174 $184.5 $106.69 72.93%
2023-06-09 8 $195 $174 $184.5 $106.69 72.93%
2023-07-18 6 $195 $174 $184.5 $106.69 72.93%
2023-08-08 5 $195 $174 $184.5 $106.69 72.93%
2023-08-10 5 $214 $195 $204.5 $106.69 91.68%
2023-09-01 6 $214 $195 $204.5 $106.69 91.68%
2023-09-12 6 $233 $195 $214 $106.69 100.58%
2023-09-14 6 $195 $116 $155.5 $106.69 45.75%
2023-10-03 8 $116 $97.5 $106.75 $106.69 0.06%
2023-10-11 8 $116 $105 $110.5 $106.69 3.57%
2023-11-06 10 $125.2 $105 $115.1 $106.69 7.88%
2023-12-01 12 $125.2 $105 $116.733 $106.69 9.41%
2023-12-06 11 $125.2 $115 $120.1 $106.69 12.57%

The Trend in the Analyst Price Target


NVO's average price target has moved up $53.82 over the prior 43 months.

Over the past 45 weeks, NVO's average upside potential has been 9%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-01 8 147.0 145 146.0 139.08 4.98%
2023-02-01 8 155.0 147 151.0 139.08 8.57%
2023-04-13 9 174.0 155 164.5 167.64 -1.87%
2023-07-18 5 195.0 174 184.5 160.25 15.13%
2023-11-06 11 125.2 105 115.1 101.08 13.87%

NVO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.82 8 0 1 1 1 11

The Trend in the Broker Recommendations


Over the past 25 months, NVO's average broker recommendation rating improved by 0.65.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVO as an investment opportunity.

  • In the context of stocks in the mega market cap category, NOVO NORDISK A S's number of analysts covering the stock is greater than 193.43% of them.
  • NVO has a lower variance in analysts' estimates than -243.01% of stocks in the mega market cap category.
  • NVO has a greater average analyst price target than 3201.05% of Pharmaceutical Products stocks.
  • NOVO NORDISK A S's upside potential (average analyst target price relative to current price) is higher than 2573.96% of stocks in the mega market cap category.

Stocks similar to NOVO NORDISK A S in the Pharmaceutical Products industry regarding analyst recommendations and price targets are AZN, NVS, and ABBV.

What is the outlook for NVO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!